(Q33540394)

27 July 2017

1 reference

title

The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment (English)

1 reference

27 July 2017

0 references

Ghosh P

1

1 reference

27 July 2017

publication date

1 February 1999

1 reference

Seminars in Arthritis and Rheumatism

27 July 2017

published in

1 reference

27 July 2017

volume

28

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

211-267

1 reference

The occurrence of osteoarthritis outside Europe

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Epidemiology of hip and knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Occurrence of osteoarthritis of the peripheral joints in European populations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Assessing cost-effectiveness analyses in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The involvement of subchondral mineralized tissues in osteoarthrosis: quantitative microscopic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Cartilage and subchondral bone interaction in osteoarthrosis of human knee joint: a histological and histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Histomorphometric changes in the trabecular structure of a selected stress region in the femur in patients with osteoarthritis and fracture of the femoral neck.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Intraosseous thrombosis in ischemic necrosis of bone and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Subchondral avascular necrosis: a common cause of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Variability in the immunochemical quantification of keratan sulphate in human and bovine cartilage proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Proteinase-mediated cartilage degradation in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Free radicals in biological systems--a review orientated to inflammatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Clinical biology of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Plasma proteins in synovial fluids of normal human joints

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Nitric oxide and cartilage metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Costs and effectiveness of nonsteroidal anti-inflammatory drugs: the importance of reducing side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

1 reference

7 January 2021

Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effects of meloxicam compared to acetylsalicylic acid in human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Chondroneutrality of meloxicam in rats with spontaneous osteoarthrosis of the ankle joint

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effects of tiaprofenic acid (Surgam) on cartilage proteoglycans in the rabbit joint immobilisation model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Slow-acting, disease-modifying osteoarthritis agents

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Preferential localization of 3H-pentosanpolysulphate to the urinary tract in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The periphery of the developing collagen fibril. Quantitative relationships with dermatan sulphate and other surface-associated species

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

1 reference

7 January 2021

Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The effects of loading on the synthesis of biglycan and decorin in intact mature articular cartilage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Joint destruction in arthritis: metalloproteinases in the spotlight

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Degradation of proteoglycans in human osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Matrix metalloproteinases: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Evaluation of the effect of antiarthritic drugs on the secretion of proteoglycans by lapine chondrocytes using a novel assay procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Cartilage proteoglycans: structure and potential functions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

[STUDIES ON THE CHEMISTRY OF THE ARTERIAL WALL. VII. PURIFICATION AND PROPERTIES OF BETA-ACETYLGLUCOSAMINIDASE FROM THE AORTA OF CATTLE]

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Modulation of interleukin-1–induced alterations in cartilage proteoglycan metabolism by activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Involvement of protein kinase C in the interleukin 1 alpha-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Involvement of protein kinase A and C in the production of interleukin-1 alpha-induced prostaglandin E2 from mouse osteoblast-like cell line, MC3T3-E1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The interaction of pentosan polysulphate (SP54) with human neutrophil elastase and connective tissue matrix components

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Inhibition of human elastase from polymorphonuclear leucocytes by gold sodium thiomalate and pentosan polysulfate (SP-54®)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Studies on the effect of pentosan polysulfate on proteoglycan degradation by leukocyte neutral proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Purification and some properties of a neutral protease from human leukocyte granules and its comparison with pancreatic elastase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The chondroprotective drugs, Arteparon and sodium pentosan polysulphate, increase collagenase activity and inhibit stromelysin activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Experimentally induced corticosteroid arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Proteoglycan aggregate synthesis in normal and chronically hydrocortisone-suppressed rabbit articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

A pharmacological and histological examination of the microcirculation of the rat subcutaneous air-pouch: microcirculation of the rat air-pouch.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Application of an enzyme-linked immunosorbent-inhibition assay to quantitate the release of KS peptides into fluids of the rat subcutaneous air-pouch model and the effects of chondroprotective drugs on the release process

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The effects of orally administered calcium pentosan polysulfate on inflammation and cartilage degradation produced in rabbit joints by intraarticular injection of a hyaluronate-polylysine complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Animal models for osteoarthritis: processes, problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection. Effect of surgical hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The synovial changes in post-traumatic synovitis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Comparison of blood and synovial fluid lymphocyte subsets in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Evaluation of synovial cytokine patterns in rheumatoid arthritis and osteoarthritis by quantitative reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Oncoprotein expression in human synovial tissue: an immunohistochemical study of different types of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Increased levels of proteoglycan fragments in knee joint fluid after injury

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture--synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Connective tissue antigens stimulate collagenase production in arthritic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Cellular immune response toward human articular chondrocytes. T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Experimental arthritis induced by intraarticular injection of allogenic cartilaginous particles into rabbit knees

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Evidence that a humoral immune response to autologous cartilage proteoglycan can participate in the induction of cartilage pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Increased interleukin 1 beta production of macrophages by proteoglycan fragments deriving from articular cartilage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Autoimmune recognition of cartilage collagens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Pharmacological Studies on the Anti-Inflammatory Effect of a Semi-Synthetic Polysaccharide (Pentosan Polysulfate)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Inflammatory cytokines and enzymes in synovial fluid of patients with rheumatoid arthritis and other arthritides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Interleukin-1 beta induces synthesis and secretion of interleukin-6 in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The effect of additive hyaluronic acid on animal joints with experimentally reduced lubricating ability

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The role of hyaluronic acid in joint stability--a hypothesis for hip dysplasia and allied disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Increased friction of animal joints by experimental degeneration and recovery by addition of hyaluronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Osteoarthritis and hyaluronan--palliative or disease-modifying treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Interactions of hyaluronan (hyaluronic acid) with phospholipids as determined by gel permeation chromatography, multi-angle laser-light-scattering photometry and 1H-NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The Biochemistry of the Human Synovial Lining with Special Reference to Alterations in Metabolism in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Synovial intimal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Pentosan polysulphate and glycosaminoglycan polysulphate stimulate the synthesis of hyaluronan in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Interactions of pentosan polysulfate with cartilage matrix proteins and synovial fibroblasts derived from patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Osteoarthritis of the hip: a study of the nature and evolution of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Intramedullary pressure of the patella in Chondromalacia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Intraosseous Pressure in the Patella in Relation to Simulated Joint Effusion and Knee Position:An Experimental Study in Puppies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Intraosseous pressure and partial pressures of oxygen and carbon dioxide in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Microvascular obstruction in avascular necrosis. Immunohistochemistry of 14 femoral heads.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Mechanisms of inflammation and leukocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Inflammation: They're not just for clots anymore

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effect of Pentosan Polysulfate on Activated Partial Thromboplastin Time, Thrombin Time, Euglobulin Clot Lysis, and on Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor Activities in Patients with Thromboembolic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Comparison of the effects of sodium pentosanpolysulfate and unfractionated heparin on venous thrombosis; an experimental study in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Platelets and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effects of a sulphated xylan on aggregation of human blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Anticoagulant activities of a pentosane polysulphate: Comparison with standard heparin and a fraction of low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

In vivo release of anti-Xa clotting activity by a heparin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Kinetic Considerations on the Physiologic Control of Thrombin and Factor Xa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effect of Pentosan Polysulfate on Fibrinolysis: Basic Tests and Clinical Application

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Influence of heparin; of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effect of the heparinoid pentosan polysulphate (SP 54) on the functional properties of cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Release of plasminogen activator by pentosan polysulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

A comparison of the lipolytic and anticoagulative properties of heparin and pentosan polysulphate in the thoroughbred horse

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The effects of post-heparin plasma lipases on anti-Xa clotting activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Use of anti-inflammatory and analgesic drugs in dogs and cats

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Systemic use of pentosan polysulphate in the treatment of osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

An enzyme-linked immunosorbent-inhibition assay for quantitation of hyaluronan (hyaluronic acid) in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

ECM and cell surface proteolysis: regulating cellular ecology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Plasmin degradation of cartilage proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The degradation of articular collagen by neutrophil proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Degradation of cartilage collagens type II, IX, X and XI by enzymes derived from human articular chondrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Biotin-Labeled Potato Chymotrypsin Inhibitor-1: A Useful Probe for the Detection and Quantitation of Chymotrypsin-like Serine Proteinases on Western Blots and Its Application in the Detection of a Serine Proteinase Synthesized by Articular Chondrocyt

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Characterization of proteoglycan degradation by calpain

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

Catabolism of Hyaluronan in the Knee Joint of the Rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2899%2980021-3

7 January 2021

10.1016/S0049-0172(99)80021-3

Identifiers

DOI

1 reference

27 July 2017

1 reference